rxstat › Drug prices › Metformin Empagliflozin

Metformin Empagliflozin (Synjardy) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Metformin Empagliflozin 5 mg / 500 mg tablet costs about $1.38 to $1.45 per tablet on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Metformin Empagliflozin has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKONNBNS
5 mg / 500 mg Tabletper tablet$1.42$1.42$1.45$1.38$1.43
5 mg / 850 mg Tabletper tablet$1.42$1.42$1.45$1.38$1.43
5 mg / 1000 mg Tabletper tablet$1.42$1.42$1.45$1.38$1.43
12.5 mg / 500 mg Tabletper tablet$1.42$1.42$1.45$1.38$1.43
12.5 mg / 850 mg Tabletper tablet$1.42$1.42$1.45$1.38$1.43
12.5 mg / 1000 mg Tabletper tablet$1.42$1.42$1.45$1.38$1.43
Plan coverageCoveredSpecial approvalCoveredSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 6 products
  • Synjardy 5 mg / 500 mg Tablet · BOE
    DIN 02456575 · $1.42/tablet · Covered
  • Synjardy 5 mg / 850 mg Tablet · BOE
    DIN 02456583 · $1.42/tablet · Covered
  • Synjardy 5 mg / 1000 mg Tablet · BOE
    DIN 02456591 · $1.42/tablet · Covered
  • Synjardy 12.5 mg / 500 mg Tablet · BOE
    DIN 02456605 · $1.42/tablet · Covered
  • Synjardy 12.5 mg / 850 mg Tablet · BOE
    DIN 02456613 · $1.42/tablet · Covered
  • Synjardy 12.5 mg / 1000 mg Tablet · BOE
    DIN 02456621 · $1.42/tablet · Covered
Saskatchewan: 6 products
  • Synjardy 5 mg / 500 mg Tablet · BOE
    DIN 02456575 · $1.42/tablet · Special approval
  • Synjardy 5 mg / 850 mg Tablet · BOE
    DIN 02456583 · $1.42/tablet · Special approval
  • Synjardy 5 mg / 1000 mg Tablet · BOE
    DIN 02456591 · $1.42/tablet · Special approval
  • Synjardy 12.5 mg / 500 mg Tablet · BOE
    DIN 02456605 · $1.42/tablet · Special approval
  • Synjardy 12.5 mg / 850 mg Tablet · BOE
    DIN 02456613 · $1.42/tablet · Special approval
  • Synjardy 12.5 mg / 1000 mg Tablet · BOE
    DIN 02456621 · $1.42/tablet · Special approval
Ontario: 6 products
  • Synjardy 5 mg / 1000 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02456591 · $1.45/tablet · Covered
  • Synjardy 5 mg / 500 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02456575 · $1.45/tablet · Covered
  • Synjardy 5 mg / 850 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02456583 · $1.45/tablet · Covered
  • Synjardy 12.5 mg / 1000 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02456621 · $1.45/tablet · Covered
  • Synjardy 12.5 mg / 500 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02456605 · $1.45/tablet · Covered
  • Synjardy 12.5 mg / 850 mg Tablet · Boehringer-Ingelheim (Canada) Ltd./Ltee
    DIN 02456613 · $1.45/tablet · Covered
New Brunswick: 6 products
  • Synjardy 5 mg / 500 mg Tablet · BOE
    DIN 02456575 · $1.38/tablet · Special approval
  • Synjardy 5 mg / 850 mg Tablet · BOE
    DIN 02456583 · $1.38/tablet · Special approval
  • Synjardy 5 mg / 1000 mg Tablet · BOE
    DIN 02456591 · $1.38/tablet · Special approval
  • Synjardy 12.5 mg / 500 mg Tablet · BOE
    DIN 02456605 · $1.38/tablet · Special approval
  • Synjardy 12.5 mg / 850 mg Tablet · BOE
    DIN 02456613 · $1.38/tablet · Special approval
  • Synjardy 12.5 mg / 1000 mg Tablet · BOE
    DIN 02456621 · $1.38/tablet · Special approval
Nova Scotia: 6 products
  • Synjardy 5 mg / 500 mg Tablet · BOE
    DIN 02456575 · $1.43/tablet · Special approval
  • Synjardy 5 mg / 850 mg Tablet · BOE
    DIN 02456583 · $1.43/tablet · Special approval
  • Synjardy 5 mg / 1000 mg Tablet · BOE
    DIN 02456591 · $1.43/tablet · Special approval
  • Synjardy 12.5 mg / 500 mg Tablet · BOE
    DIN 02456605 · $1.43/tablet · Special approval
  • Synjardy 12.5 mg / 850 mg Tablet · BOE
    DIN 02456613 · $1.43/tablet · Special approval
  • Synjardy 12.5 mg / 1000 mg Tablet · BOE
    DIN 02456621 · $1.43/tablet · Special approval

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 3
Reports on file
6

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
SYNJARDY
500MG 12.5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02456605 · ended Apr 11, 2023 · Inbound Logistics Delay - No Patient Impact expected due to 2-3 weeks inventory on hand at wholesalers
Avoided
SYNJARDY
1000MG 12.5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02456621 · ended Mar 29, 2023 · Anticipated Shortage due to Inbound Logistics Delay Averted - No Patient Impact expected due to 2-3 weeks inventory on hand at wholesalers
Resolved
SYNJARDY
500MG 5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02456575 · ended Jun 20, 2022 · Disruption of the manufacture of the drug.
Resolved
SYNJARDY
5MG 500MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02456575 · ended Nov 10, 2020 · Disruption of the manufacture of the drug.
Resolved
SYNJARDY
12.5MG 1000MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02456621 · ended Nov 10, 2020 · Disruption of the manufacture of the drug.
Resolved
SYNJARDY
500MG 5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02456575 · ended Aug 23, 2019 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Metformin Empagliflozin. Health Canada has 6 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Metformin Empagliflozin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).

Recent changes

Common questions

How much does Metformin Empagliflozin cost in Canada?

Metformin Empagliflozin 5 mg / 500 mg tablet costs about $1.38 to $1.45 per tablet on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee.

Is Metformin Empagliflozin covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Metformin Empagliflozin be back in stock in Canada?

Metformin Empagliflozin has no active shortage; supply is normal per Health Canada reports.

Why is Metformin Empagliflozin in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (blood glucose lowering drugs, excl. insulins)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.